Raez LE - Search Results

1

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.

Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME, Barlesi F, Bivona T, Diehn M, Dive C, Dziadziuszko R, Leighl N, Malapelle U, Mok T, Peled N, Raez LE, Sequist L, Sholl L, Swanton C, Abbosh C, Tan D, Wakelee H, Wistuba I, Bunn R, Freeman-Daily J, Wynes M, Belani C, Mitsudomi T, Gandara D. Rolfo C, et al. Among authors: raez le. J Thorac Oncol. 2021 Oct;16(10):1647-1662. doi: 10.1016/j.jtho.2021.06.017. Epub 2021 Jul 8. J Thorac Oncol. 2021. PMID: 34246791 Free article. Review.

2

Chemotherapy for advanced non-small-cell lung cancer.

Raez LE, Lilenbaum R. Raez LE, et al. Clin Adv Hematol Oncol. 2004 Mar;2(3):173-8. Clin Adv Hematol Oncol. 2004. PMID: 16166948 Review.

3

New developments in chemotherapy for advanced non-small cell lung cancer.

Raez LE, Lilenbaum R. Raez LE, et al. Curr Opin Oncol. 2006 Mar;18(2):156-61. doi: 10.1097/01.cco.0000208789.37689.6b. Curr Opin Oncol. 2006. PMID: 16462185 Review.

4

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC).

Raez LE, Santos ES, Lopes G, Rosado MF, Negret LM, Rocha-Lima C, Tolba K, Farfan N, Hamilton-Nelson K, Silva O, Roman E. Raez LE, et al. Lung Cancer. 2006 Sep;53(3):347-53. doi: 10.1016/j.lungcan.2006.05.023. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844257 Clinical Trial.

5

Present and future of lung cancer vaccines.

Raez LE, Rosenblatt JD, Podack ER. Raez LE, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):445-59. doi: 10.1517/14728214.11.3.445. Expert Opin Emerg Drugs. 2006. PMID: 16939384 Review.

6

Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.

Lilenbaum R, Raez L, Tseng J, Seigel L, Davila E. Lilenbaum R, et al. J Thorac Oncol. 2008 May;3(5):511-5. doi: 10.1097/JTO.0b013e31816de28f. J Thorac Oncol. 2008. PMID: 18449004 Free article. Clinical Trial.

7

Second-line therapy for non-small-cell lung cancer.

Arango BA, Castrellon AB, Santos ES, Raez LE. Arango BA, et al. Among authors: raez le. Clin Lung Cancer. 2009 Mar;10(2):91-8. doi: 10.3816/CLC.2009.n.011. Clin Lung Cancer. 2009. PMID: 19362951 Review.

8

Gene expression profiling and non-small-cell lung cancer: where are we now?

Santos ES, Blaya M, Raez LE. Santos ES, et al. Among authors: raez le. Clin Lung Cancer. 2009 May;10(3):168-73. doi: 10.3816/CLC.2009.n.023. Clin Lung Cancer. 2009. PMID: 19443336 Review.

9

Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer.

Raez LE, Kobina S, Santos ES. Raez LE, et al. Clin Lung Cancer. 2010 Jan;11(1):18-24. doi: 10.3816/CLC.2010.n.003. Clin Lung Cancer. 2010. PMID: 20085863 Review.

10

Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung cancer.

Bastos BR, Hatoum GF, Walker GR, Tolba K, Takita C, Gomez J, Santos ES, Lopes G, Raez LE. Bastos BR, et al. Among authors: raez le. J Thorac Oncol. 2010 Apr;5(4):533-9. doi: 10.1097/JTO.0b013e3181ce3e00. J Thorac Oncol. 2010. PMID: 20357618 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page